BioCentury | Apr 29, 2020
Product Development

India emerging as major COVID-19 vaccine manufacturer

...for manufacturing CoroFlu. Clinical trials could start this fall, according to the University of Wisconsin. Zydus...
...vaccine. The latter is being developed by Zydus unit Etna Biotech, an Italian company that Zydus...
BioCentury | Apr 21, 2020
Product Development

Trio of tactics to target COVID-19 hyperinflammation

...targeting a total raise of £15 from the private sector. Zydus pursuing long-acting interferon treatment Zydus...
...viral load and levels of IL-6, as well as generate a virus-eliminating specific immune response. Zydus...
BioCentury | Aug 3, 2019
Emerging Company Profile

Bringing CAR T to India

...backed by some of India’s most prominent executives, including Pankaj Patel, founder and chairman of Zydus...
BioCentury | Apr 10, 2019
Distillery Therapeutics

Imidazopyrimidine-based inhibitor of Leishmania proteasome identified to treat visceral leishmaniasis

...testing GSK3494245 in preclinical models of visceral leishmaniasis. Knight Therapeutics Inc., Profounda Inc., Roche and Zydus...
BioCentury | Aug 16, 2018
Company News

Management tracks: Achillion, Navidea

...its U.S. subsidiary. She was SVP of sales and marketing at the U.S. division of Zydus...
BioCentury | Aug 24, 2017
Translation in Brief

The skinny on leishmaniasis

...cholinephosphate cytidyltransferase inhibitor, from Knight Therapeutics Inc. (TSX:GUD), Profounda Inc. , Roche (SIX:ROG; OTCQX:RHHBY) and Zydus...
BioCentury | Jul 18, 2017
Distillery Therapeutics

Infectious disease

...models of S. aureus infections. Knight Therapeutics Inc. , Profounda Inc. , Roche , and Zydus...
BioCentury | Feb 22, 2017
Distillery Therapeutics

Infectious disease additional models of leishmaniasis. Knight Therapeutics Inc. , Profunda Inc. , Roche , and Zydus...
BioCentury | Jul 25, 2016

Paving the way

...for regulatory submissions are shown below. Source: BCIQ: BioCentury Online Intelligence Company Status (submission plan) Zydus...
BioCentury | Dec 10, 2015
Distillery Therapeutics

Therapeutics: An undetermined target

...steps could include optimization of the most potent compounds. Knight Therapeutics Inc. , Roche and Zydus...
Items per page:
1 - 10 of 47